Moreover, PZH can regulate the levels of signaling proteins involved in late cancer progression, including basal and activated forms (phosphorylated) of AKT and mTOR, as well as cell cyle modulators (CDK4, CDK6), tumor supressor genes and proto-oncogenes (p53 and c-Myc, respectively). The gene discussed is MYC; the disease is neoplasm.